Lubrizol Forms Partnership with IMCD to Expand Medical Solutions Business in North America

Lubrizol, a key player in the medical grade thermoplastic polyurethane (TPU) solutions sector, has formed a distribution agreement with IMCD to meet the demand for medical solutions in the U.S. and Canada. The partnership aims to expand a well-established medical TPU in Europe to North America. IMCD will be able to strengthen customer relationships, efficiently manage inventory, and enhance market penetration.

Lubrizol offers a wide range of medical-grade TPU solutions as well as differentiated design, development, and manufacturing services for medical devices. IMCD is a prominent partner in the distribution and formulation of speciality chemicals and ingredients. The company has consolidated its position in the healthcare market by leveraging partnerships with prominent suppliers and a diverse customer base, thereby developing expertise in medical-grade polymers.

“We are delighted to broaden our distribution with IMCD to include North America, as this enables us to continue as the most trusted partner in the medical device industry, with service levels and the best-in-class materials our customers expect,” said Lu Zhang, Vice President for Engineered Polymers & Medical Solutions.

“This new North American distribution agreement adds another layer to the strong, successful distribution partnership IMCD and Lubrizol have enjoyed for many years,” said Jean-Paul Scheepens, President of IMCD US. “We are eager to bring Lubrizol innovation to new customers.”

Source: Lubrizol